Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice

Vaccine

Volumn 27, Issue 37, 2009, Pages 5069-5076

  Lico, Chiara ^a   Mancini, Camillo ^a   Italiani, Paola ^b   Betti, Camilla ^a   Boraschi, Diana ^b   Benvenuto, Eugenio ^a   Baschieri, Selene ^a  

^a ENEA C R CASACCIA   (Italy)

^b CNR   (Italy)

Author keywords

Chimeric plant virus particles; IFN secreting CD8+ T cell; Peptide vaccine

Indexed keywords

CHIMERIC PROTEIN; EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS NUCLEOPROTEIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DRUG FORMULATION; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENE SEQUENCE; GENETIC ENGINEERING; GENETIC STABILITY; INFLUENZA VIRUS A; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANT VIRUS; POTEXVIRUS; PRIORITY JOURNAL; SPLEEN CELL; VIRUS CARRIER; VIRUS INFECTIVITY; VIRUS PARTICLE;

ANIMALS; ANTIBODIES, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLUENZA A VIRUS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; PLANTS, GENETICALLY MODIFIED; POTEXVIRUS; RNA-BINDING PROTEINS; TOBACCO; VIRAL CORE PROTEINS;

EID: 67650738556     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.045     Document Type: Article

References (39)

1. Purcell A.W., McCluskey J., and Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov 6 6 (2007) 404-414
2. Pogue G.P., Lindbo J.A., Garger S.J., and Fitzmaurice W.P. Making an ally from an enemy: plant virology and the new agriculture. Annu Rev Phytopathol 40 (2002) 45-74
3. McCormick A.A., Corbo T.A., Wykoff-Clary S., Nguyen L.V., Smith M.L., Palmer K.E., et al. TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models. Vaccine 24 40-41 (2006) 6414-6423
4. Leclerc D., Beauseigle D., Denis J., Morin H., Pare C., Lamarre A., et al. Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells. J Virol 8 3 (2007) 1319-1326
5. Baratova L.A., Grebenshchikov N.I., Shishkov A.V., Kashirin I.A., Radavsky J.L., Jarvekulg L., et al. The topography of the surface of potato virus X: tritium planigraphy and immunological analysis. J Gen Virol 73 Pt 2 (1992) 229-235
6. Marusic C., Rizza P., Lattanzi L., Mancini C., Spada M., Belardelli F., et al. Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. J Virol 75 18 (2001) 8434-8439
7. Lico C., Capuano F., Renzone G., Donini M., Marusic C., Scaloni A., et al. Peptide display on Potato virus X: molecular features of the coat protein-fused peptide affecting cell-to-cell and phloem movement of chimeric virus particles. J Gen Virol 87 Pt 10 (2006) 3103-3112
8. Uhde K., Fischer R., and Commandeur U. Expression of multiple foreign epitopes presented as synthetic antigens on the surface of Potato virus X particles. Arch Virol 150 2 (2005) 327-340
9. Milne R.G., and Lesemann D.E. Immunosorbent electron microscopy in plant virus studies. Meth Virol 8 (1984) 85-101
10. Gileadi U., Gallimore A., Van der Bruggen P., and Cerundolo V. Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes. Eur J Immunol 29 7 (1999) 2213-2222
11. Shastri N., Serwold T., and Gonzalez F. Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues. J Immunol 155 9 (1995) 4339-4346
12. Lico C., Baschieri S., Marusic C., and Benvenuto E. Molecular farming for antigen (vaccine) production in plants. In: Ranalli P. (Ed). Improvement of crop plants for industrial end uses (2007), Springer, New York 417-433
13. Mason H.S., Warzecha H., Mor T., and Arntzen C.J. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med 8 7 (2002) 324-329
14. Scholthof H.B., Scholthof K.B., and Jackson A.O. Plant virus gene vectors for transient expression of foreign proteins in plants. Annu Rev Phytopathol 34 (1996) 299-323
15. Appay V., Douek D.C., and Price D.A. CD8+ T cell efficacy in vaccination and disease. Nat Med 14 6 (2008) 623-628
16. Braciale T.J., Morrison L.A., Sweetser M.T., Sambrook J., Gething M.J., and Braciale V.L. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol Rev 98 (1987) 95-114
17. Welsh R.M., and Fujinami R.S. Pathogenic epitopes, heterologous immunity and vaccine design. Nature Rev Microbiol 5 7 (2007) 555-563
18. Kovacsovics-Bankowski M., and Rock K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267 5195 (1995) 243-246
19. Behrens G., Li M., Smith C.M., Belz G.T., Mintern J., Carbone F.R., et al. Helper T cells, dendritic cells and CTL Immunity. Immunol Cell Biol 82 1 (2004) 84-90
20. Bennett S.R., Carbone F.R., Karamalis F., Miller J.F., and Heath W.R. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 186 1 (1997) 65-70
21. Denis J., Majeau N., Acosta-Ramirez E., Savard C., Bedard M.C., Simard S., et al. Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization. Virology 363 1 (2007) 59-68
22. Lacasse P., Denis J., Lapointe R., Leclerc D., and Lamarre A. Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation. J Virol 82 2 (2008) 785-794
23. McCormick A.A., Corbo T.A., Wykoff-Clary S., Palmer K.E., and Pogue G.P. Chemical conjugate TMV-peptide bivalent fusion vaccines improve cellular immunity and tumor protection. Bioconjug Chem 17 5 (2006) 1330-1338
24. Bui H.H., Peters B., Assarsson E., Mbawuike I., and Sette A. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci USA 104 1 (2007) 246-251
25. Townsend A.R., Rothbard J., Gotch F.M., Bahadur G., Wraith D., and McMichael A.J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44 6 (1986) 959-968
26. Belz G.T., Stevenson P.G., and Doherty P.C. Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses. J Immunol 165 5 (2000) 2404-2409
27. Santa-Cruz S., Chapman S., Roberts A.G., Roberts I.M., Prior D.A., and Oparka K.J. Assembly and movement of a plant virus carrying a green fluorescent protein overcoat. Proc Natl Acad Sci USA 93 13 (1996) 6286-6290
28. Sloane-Lancaster J., and Allen M.P. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol 14 (1996) 1-27
29. Brander C., Yang O.O., Jones N.G., Lee Y., Goulder P., Johnson R.P., et al. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences. J Virol 73 12 (1999) 10191-10198
30. Lippolis J.D., Mylin L.M., Simmons D.T., and Tevethia S.S. Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen. J Virol 69 5 (1995) 3134-3146
31. Rueda P., Moron G., Sarraseca J., Leclerc C., and Casal J.I. Influence of flanking sequences on presentation efficiency of a CD8+ cytotoxic T-cell epitope delivered by parvovirus-like particles. J Gen Virol 85 Pt 3 (2004) 563-572
32. Livingston B.D., Newman M., Crimi C., McKinney D., Chesnut R., and Sette A. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 19 32 (2001) 4652-4660
33. Sette A., Newman M., Livingston B., McKinney D., Sidney J., Ishioka G., et al. Optimizing vaccine design for cellular processing, MHC binding and TCR recognition. Tissue Antigens 59 6 (2002) 443-451
34. Lalvani A., Brookes R., Hambleton S., Britton W.J., Hill A.V., and McMichael A.J. Rapid effector function in CD8+ memory T cells. J Exp Med 186 6 (1997) 859-865
35. Jegerlehner A., Tissot A., Lechner F., Sebbel P., Erdmann I., Kundig T., et al. A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. Vaccine 20 25-26 (2002) 3104-3112
36. Aguilar J.C., and Rodriguez E.G. Vaccine adjuvants revisited. Vaccine 25 19 (2007) 3752-3762
37. Mandl S., Hix L., and Andino R. Preexisting immunity to poliovirus does not impair the efficacy of recombinant poliovirus vaccine vectors. J Virol 75 2 (2001) 622-627
38. Ruedl C., Schwarz K., Jegerlehner A., Storni T., Manolova V., and Bachmann M.F. Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies. J Virol 79 2 (2005) 717-724
39. De Berardinis P., Sartorius R., Fanutti C., Perham R.N., Del Pozzo G., and Guardiola J. Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses. Nat Biotechnol 18 8 (2000) 873-876